Detalles de la búsqueda
1.
Cost-Effectiveness of Empagliflozin (Jardiance®) 10 Mg And 25 Mg Administered As An Add-on To Metformin Compared To Other Sodium-Glucose Co-Transporter 2 Inhibitors (Sglt2is) for Patients With Type 2 Diabetes Mellitus (T2dm) In The UK.
Value Health
; 17(7): A350-1, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27200679
2.
Cost-Effectiveness of Empagliflozin (Jardiance®) 10 Mg And 25 Mg Administered As An Add-On To Metformin And Sulfonilurea (Met+Su) Compared To Other Sodium-Glucose Co-Transporter 2 Inhibitors (Sglt2is) in Patients with Type 2 Diabetes Mellitus (T2dm) In The Uk.
Value Health
; 17(7): A351, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27200682
3.
Development Of A Model To Assess The Cost-Effectiveness Of Therapies For Patients With Type 2 Diabetes Mellitus (T2DM) Following A Reference Model Framework.
Value Health
; 17(7): A562, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27201858
4.
A systematic review of duplex ultrasound, magnetic resonance angiography and computed tomography angiography for the diagnosis and assessment of symptomatic, lower limb peripheral arterial disease.
Health Technol Assess
; 11(20): iii-iv, xi-xiii, 1-184, 2007 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-17462170
5.
Economic evaluation.
Singapore Med J
; 47(6): 456-61; quiz 462, 2006 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-16752012
Resultados
1 -
5
de 5
1
Próxima >
>>